Executing M&A in Healthcare

General

· EPISODE

257

The healthcare industry is a complex and rigid space where change is often rejected. Any evolution in this sector not only signifies business decisions but also influences the overall quality and accessibility of patient care. In this episode, Roy Schoenberg, President & Co-CEO at Amwell, delves into the intricacies of navigating M&A in the healthcare industry.

Listen on Apple Listen to Spotify

wn3_IPJAokY

872427297

Listen to Spotify Listen on Apple

https://traffic.libsyn.com/dealroom/FINAL_MA_Science_-_Executing_MA_in_Healthcare.mp3

Roy Schoenberg, President & Co-CEO at Amwell - American Well Corporation (NYSE:AMWL)

‍

In this episode of the M&A Science Podcast, Roy Schoenberg, President & Co-CEO at Amwell, delves into the intricacies of navigating M&A in the healthcare industry.

‍

Things you will learn:

‍

M&A in healthcare
The 3 cycles of due diligence
What makes the healthcare space distinct
Retaining key people
Approaching deals as one of the main principal

‍

Roy Schoenberg

Dr. Roy Schoenberg is the Founder and Executive Vice Chairman of Amwell, a leading telehealth ecosystem. Over his 18 years as CEO, he guided Amwell to become a global force in digitally connecting healthcare stakeholders. Before Amwell, Roy founded CareKey and served as Chief Information Security Officer at TriZetto post-acquisition. He has significantly contributed to the telehealth field, including his role in the Federation of State Medical Boards’ Taskforce for telemedicine guidelines. Roy has extensive M&A experience, having strategically positioned Amwell for industry leadership through key acquisitions and partnerships.

TAKE THE NEXT STEP

Turn what you heard into a repeatable M&A practice.

Explore the Buyer-Led M&A Certification for practical frameworks, tools, and decision-making habits you can apply on your next deal.

Explore certification